http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200031482-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7943e1a1abf9c1fe0154d63f82fbd0 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-8813 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate | 2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3befe3016a0f2b81264f3f98966a0ec4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41aa465edae9d8136381f96ad4f10b7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_190cdcf90d78da9d12268d1b4e4d12ed |
publicationDate | 2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20200031482-A |
titleOfInvention | A method of diagnosing cholangiocarcinoma |
abstract | The present invention relates to a method for determining benign biliary disease patients, pancreatic cancer and biliary cancer by measuring GCA (glycocholic acid) and TCDCA (Taurochenodeoxycholic acid) in patients with biliary cancer, and in detail, for patients with benign biliary disease, pancreatic cancer, biliary cancer As a result of measuring GCA (glycocholic acid) and TCDCA (Taurochenodeoxycholic acid) in bile, patients with biliary cancer confirmed that GCA (glycocholic acid) was high, TCDCA (Taurochenodeoxycholic acid) was low, GCA (glycocholic acid) and TCDCA (Taurochenodeoxycholic acid) ) Is a biomarker that can distinguish biliary cancer patients among patients with benign biliary disease, pancreatic cancer and biliary cancer, and uses them to diagnose biliary cancer in patients with pancreatic cancer, benign biliary disease, and biliary cancer It relates to a screening method. |
priorityDate | 2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 165.